Chinese Journal of Pharmacovigilance ›› 2026, Vol. 23 ›› Issue (5): 575-577.
DOI: 10.19803/j.1672-8629.20250724

Previous Articles     Next Articles

One Case of Agranulocytosis Caused by Tiopronin Enteric-Coated Capsules

DAI Biao1,2,3,4, ZHANG Song1,2,3,4, DENG Yiyun1,2,3,4, CAO Yin1,2,3,4, ZHANG Yuanyuan1,2,3,4, LI Peipei1,2,3,4, LIANG Jun1,2,3,4,*   

  1. 1Department of Pharmacy, Affiliated Psychological Hospital of Anhui Medical University, Hefei Anhui 230022, China;
    2Department of Pharmacy, Hefei Fourth People's Hospital, Hefei Anhui 230022, China;
    3Psychopharmacology Research Laboratory, Anhui Provincial Mental Health Center, Hefei Anhui 230022, China;
    4Clinical Medical Research Center of Mental and Psychological Diseases in Anhui Province, Hefei Anhui 230022, China
  • Received:2025-10-17 Published:2026-05-20

Abstract: Objective To investigate the adverse drug reaction of agranulocytosis caused by tiopronin enteric-coated capsules and provide a reference for safe medication in clinical practice. Methods One case of agranulocytosis induced by tiopronin enteric-coated capsules in a schizophrenia patient with liver injury was analyzed. Related literature was also reviewed and summarized. Results The patient developed liver injury after treatment with paliperidone extended-release tablets. Agranulocytosis accompanied by persistent fever occurred 8 days after combination therapy with tiopronin enteric-coated capsules (0.6 g·d⁻¹) for hepatoprotection. The granulocyte count returned to normal after discontinuation of the suspected drug and symptomatic treatment with anti-infectives, the human granulocyte colony-stimulating factor, and Diyu Shengbai capsules. Conclusion Potential hematologic toxicity, such as agranulocytosis, deserves attention during treatment with tiopronin enteric-coated capsules. When tiopronin is combined with antipsychotics, special attention should be paid to the patient's clinical manifestations and blood routine results.

Key words: Tiopronin, Leukopenia, Agranulocytosis, Paliperidone, Adverse Drug Reaction

CLC Number: